This company listing is no longer active
BLMH Stock Overview
Bloom Health Partners Inc. delivers health care solutions in Canada, the United States, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Bloom Health Partners Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.08 |
52 Week High | CA$0.29 |
52 Week Low | CA$0.08 |
Beta | -1.75 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -60.00% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -77.78% |
Recent News & Updates
Shareholder Returns
BLMH | CA Healthcare | CA Market | |
---|---|---|---|
7D | 0% | -1.4% | 0.4% |
1Y | -60.0% | 2.6% | 9.3% |
Return vs Industry: BLMH underperformed the Canadian Healthcare industry which returned -13% over the past year.
Return vs Market: BLMH underperformed the Canadian Market which returned -3.8% over the past year.
Price Volatility
BLMH volatility | |
---|---|
BLMH Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 4.7% |
Market Average Movement | 8.6% |
10% most volatile stocks in CA Market | 18.6% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: BLMH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BLMH's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | https://www.bloomhealthpartners.com |
Bloom Health Partners Inc. delivers health care solutions in Canada, the United States, and internationally. It offers COVID-19 testing solutions, such as RT-PCR and point-of-care rapid testing, as well as RT-PCR mail-in-kits. The company was formerly known as Maitri Health Technologies Corp.and changed its name to Bloom Health Partners Inc. in October 2021.
Bloom Health Partners Inc. Fundamentals Summary
BLMH fundamental statistics | |
---|---|
Market cap | CA$3.81m |
Earnings (TTM) | CA$3.58m |
Revenue (TTM) | CA$34.81m |
1.1x
P/E Ratio0.1x
P/S RatioIs BLMH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BLMH income statement (TTM) | |
---|---|
Revenue | CA$34.81m |
Cost of Revenue | CA$13.71m |
Gross Profit | CA$21.09m |
Other Expenses | CA$17.51m |
Earnings | CA$3.58m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.075 |
Gross Margin | 60.60% |
Net Profit Margin | 10.28% |
Debt/Equity Ratio | 0% |
How did BLMH perform over the long term?
See historical performance and comparison